BAICX | JNBAX | BAICX / JNBAX | |
Total Expense Ratio | 0.82 | 0.75 | 109% |
Annual Report Gross Expense Ratio | 0.92 | 1.07 | 86% |
Fund Existence | 17 years | 18 years | - |
Gain YTD | 6.817 | 7.806 | 87% |
Front Load | 5% | 5% | 117% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | 100 | N/A | - |
Net Assets | 10.5B | 8.35B | 126% |
Annual Yield % from dividends | 5.65 | 5.62 | 100% |
Returns for 1 year | 10.03 | 10.99 | 91% |
Returns for 3 years | 26.07 | 24.06 | 108% |
Returns for 5 years | 27.16 | 23.76 | 114% |
Returns for 10 years | 54.54 | 50.84 | 107% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVRX | 9.84 | 0.07 | +0.72% |
American Century Small Cap Value R | |||
VSMPX | 286.40 | 1.25 | +0.44% |
Vanguard Total Stock Mkt Idx Instl Pls | |||
GRLLX | 20.15 | 0.08 | +0.40% |
Goldman Sachs Enhanced U.S. Equity R | |||
PGICX | 18.74 | 0.06 | +0.32% |
Virtus KAR Equity Income C | |||
FIJYX | 31.04 | N/A | N/A |
Fidelity Advisor Biotechnology Z |